Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
Cham S, Landrum MB, Keating NL, Armstrong J, Wright AA. Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance. JAMA Netw Open. 2022;5(1):e2142703. Published 2022 Jan 4. doi:10.1001/jamanetworkopen.2021.42703
University of California San Francisco